Ampio Pharmaceuticals, Inc.
SEC CIK 1411906 · AMPE · last insider filing 2023-06-13
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Buchi J Kevin | Director | filed 2021 - 2023 |
| Martino Michael A | Director · INTERIM CHAIRMAN AND CEO | filed 2021 - 2023 |
| Stevens David R | Director | filed 2011 - 2023 |
| Jobes Elizabeth Varki | Director | filed 2022 - 2022 |
| Bar-Or David | Director · Chief Scientific Officer | filed 2011 - 2022 |
| Macaluso Michael | Director · Chief Executive Officer | filed 2011 - 2022 |
| Coelho Philip H | Director | filed 2011 - 2022 |
| Giles Richard B | Director | filed 2011 - 2022 |
| Wingerter Donald B Jr | Director · Chief Executive Officer | filed 2011 - 2011 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Stokely DAN | CFO | filed 2019 - 2022 |
| Cherevka Holli | PRESIDENT AND COO | filed 2017 - 2022 |
| Chilcott, III Thomas E. | Chief Financial Officer | filed 2017 - 2018 |
| Gould Gregory A | Chief Financial Officer | filed 2014 - 2016 |
| Clift Vaughan Lennox | Chief Regulatory Affairs | filed 2011 - 2015 |
| Disbrow Joshua R. | Chief Operating Officer | filed 2013 - 2013 |
| Mcgregor Mark D | Chief Financial Officer | filed 2011 - 2013 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.